Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
For setrusumab how do you think regulators will view the clinical benefit for younger patients who are still developing versus adults who are more or less finished growing?